Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome

Neurology

Volumn 77, Issue 2, 2011, Pages 110-117

  Manconi, M ^a,b   Ferri, R ^c   Zucconi, M ^a   Clemens, S ^d   Giarolli, L ^a   Bottasini, V ^a   Ferini Strambi, L ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Ospedale Civico Lugano   (Switzerland)

^c OASI RESEARCH INSTITUTE IRCCS   (Italy)

^d EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; PLACEBO; PRAMIPEXOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; DRUG EFFICACY; FEMALE; HUMAN; IDIOPATHIC DISEASE; LOW DRUG DOSE; MALE; PERIODIC LIMB MOVEMENT DISORDER; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REM SLEEP; RESTLESS LEGS SYNDROME; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; SLEEP QUALITY; SLEEP TIME; WAKEFULNESS;

EID: 80051488954     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182242d91     Document Type: Article

References (28)

1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-119. (Pubitemid 36527231)
2. Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev 2006;10:153-167. (Pubitemid 43817594)
3. Zucconi M, Manconi M. Sleep and quality of life in restless legs syndrome. In: Verster JC, Pandi-Perumal SR, Streiner D, eds. Sleep and Quality of Life in Clinical Medicine. Totowa, NJ: Humana Press; 2008:101-106.
4. Pennestri MH, Montplaisir J, Colombo R, Lavigne G, Lanfranchi PA. Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology 2007;68: 1213-1218. (Pubitemid 46608469)
5. Ferri R, Zucconi M, Rundo F, Spruyt K, Manconi M, Ferini-Strambi L. Heart rate and spectral EEG changes accompanying periodic and non-periodic leg movements during sleep. Clin Neurophysiol 2007;118:438-448. (Pubitemid 46038815)
6. Vignatelli L, Billiard M, Clarenbach P, et al. EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep. Eur J Neurol 2006; 13:1049-1065. (Pubitemid 44434310)
7. Manconi M, Ferri R, Zucconi M, et al. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements. Sleep Med 2007;8:491-497. (Pubitemid 46991574)
8. Saletu M, Anderer P, Saletu B, et al. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole: 2: findings on periodic leg movements, arousals and respiratory variables. Neuropsychobiology 2000;41:190-199. (Pubitemid 30258977)
9. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev 1998;78:189-225. (Pubitemid 28070979)
10. Beninger RJ, Gerdjikov T. The role of signaling molecules in reward-related incentive learning. Neurotox Res 2004; 6:91-104.
11. Sibley DR, Monsma FJ Jr. Molecular biology of dopamine receptors. Trends Pharmacol Sci 1992;13:61-69.
12. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121-132. (Pubitemid 36527232)
13. Junghanns S, Glöckler T, Reichmann H. A review of the receptor-binding and pharmacokinetic properties of dopamine agonists. J Neurol 2006; 251(suppl 6):VI19 -VI23.
14. Thobois S. Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature. Clin Ther 2006;28:1-12. (Pubitemid 43254985)
15. Kvernmo T, Hartter S, Burger E. A review of the receptorbinding and pharmacokinetic properties of dopamine agonists. Clin Ther 2006;28:1065-1078. (Pubitemid 44374749)
16. American Sleep Disorders Association. Recording and scoring leg movements: The Atlas Task Force. Sleep 1993; 16:748-759.
17. Kemp B, Varri A, Rosa AC, Nielsen KD, Gade J. A simple format for exchange of digitized polygraphic recordings. Electroencephalogr Clin Neurophysiol 1992; 82:391-393.
18. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles: Brain Information Service, Brain Research Institute; 1968.
19. Ferri R, Zucconi M, Manconi M, et al. Computer-assisted detection of nocturnal leg motor activity in patients with restless legs syndrome and periodic leg movements during sleep. Sleep 2005;28:998-1004. (Pubitemid 41170936)
20. Walters AS, Hening WA, Kavey N, Chokroverty S, Gidro-Frank S. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 1988;24:455-458.
21. Bonuccelli U, Del Dotto P, Rascol O. Role of dopamine receptor agonists in the treatment of early Parkinson's disease. Parkinsonism Relat Disord 2009;15(suppl 4):S44-S53.
22. Ferri R, Manconi M, Arico D, et al. Acute dopamineagonist treatment in restless legs syndrome: effects on sleep architecture and NREM sleep instability. Sleep 2010;33: 793-800.
23. Manconi M, Ferri R, Feroah TR, Zucconi M, Ferini- Strambi L. Defining the boundaries of the response of sleep leg movements to a single dose of dopamine agonist. Sleep 2008;31:1229-1237.
24. Ondo WG, He Y, Rajasekaran S, Le WD. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord 2000;15:154-158. (Pubitemid 30038003)
25. Clemens S, Rye D, Hochman S. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 2006;67:125-130. (Pubitemid 44305475)
26. Clemens S, Sawchuk MA, Hochman S. Reversal of the circadian expression of tyrosine-hydroxylase but not nitric oxide synthase levels in the spinal cord of dopamine D3 receptor knockout mice. Neuroscience 2005;133:353-357. (Pubitemid 40726203)
27. Clemens S, Hochman S. Conversion of the modulatory actions of dopamine on spinal reflexes from depression to facilitation in D3 receptor knock-out mice. J Neurosci 2004;24:11337-11345. (Pubitemid 39658269)
28. Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol 2010;6:337-346.